Una nucleasa de anillo viral anti-CRISPR subvierte la inmunidad tipo III de CRISPR
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.Los virus pueden evadir la inmunidad CRISPR bacteriana mediante el uso de una nueva enzima, AcrIII-1, que degrada las moléculas de señalización del tetraadenilato cíclico (cA4). Este descubrimiento revela una nueva estrategia viral para desactivar los sistemas de defensa CRISPR.
Área De La Ciencia
- Microbiología
- Biología molecular
- Virología
Sus Antecedentes
- Los sistemas CRISPR-Cas proporcionan inmunidad adaptativa en procariotas contra elementos genéticos móviles.
- Los sistemas CRISPR de tipo III utilizan la proteína Cas10 para detectar el ARN viral, activando los dominios nucleasa y ciclasa para sintetizar oligoadenilatos cíclicos.
- Los oligoadenilatos cíclicos activan las enzimas de defensa aguas abajo, formando una potente respuesta antiviral que puede conducir a la extinción viral.
Objetivo Del Estudio
- Identificar nuevos mecanismos virales anti-CRISPR (Acr) dirigidos al sistema CRISPR-Cas de tipo III.
- Caracterizar una nueva familia de enzimas virales que degradan el tetraadenilato cíclico (cA4).
Principales Métodos
- Análisis bioinformático para identificar la distribución de AcrIII-1 en los genomas virales.
- Ensayos bioquímicos para determinar la especificidad del sustrato y la actividad enzimática de AcrIII-1.
- Análisis estructural para elucidar el mecanismo de unión y catalización de AcrIII-1.
Principales Resultados
- Descubrimiento de AcrIII-1, una nucleasa de anillo viral ampliamente distribuida en virus arqueos y bacterianos.
- AcrIII-1 se une específicamente y degrada rápidamente el tetraadenilato cíclico (cA4), una molécula de señalización clave en la inmunidad CRISPR de tipo III.
- AcrIII-1 posee un nuevo pliegue para la unión cA4 y un sitio activo conservado para su escisión, neutralizando efectivamente la defensa CRISPR.
- La familia AcrIII-1 exhibe un amplio rango de huéspedes al dirigirse a la molécula de señalización en lugar de a proteínas efectoras específicas.
Conclusiones
- AcrIII-1 representa un mecanismo de defensa viral significativo contra los sistemas CRISPR de tipo III.
- La degradación de cA4 por AcrIII-1 permite a los virus escapar de la inmunidad mediada por CRISPR.
- La señalización de nucleótidos cíclicos juega un papel crítico en la carrera armamentista coevolucionaria entre los virus y sus huéspedes.
Estos videos han sido emparejados automáticamente Contact us si no son relevantes
Estos videos han sido emparejados automáticamente Contact us si no son relevantes
Videos de Conceptos Relacionados
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...